Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients
about
Lung microbiology and exacerbations in COPDPulmonary-intestinal cross-talk in mucosal inflammatory diseaseDamage-Associated Molecular Patterns in the Course of Lung Cancer--A ReviewDifferent Toll-Like Receptor Expression Patterns in Progression toward CancerInfluence of age, past smoking, and disease severity on TLR2, neutrophilic inflammation, and MMP-9 levels in COPDBeta defensin-2 is reduced in central but not in distal airways of smoker COPD patientsInnate immune responses to bacterial ligands in the peripheral human lung--role of alveolar epithelial TLR expression and signallingToll-like receptors 2, 3 and 4 and thymic stromal lymphopoietin expression in fatal asthmaThe TGF-beta-pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzae.Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes.Cigarette smoke exposure exacerbates lung inflammation and compromises immunity to bacterial infection.Investigation of Toll-like receptors in the pathogenesis of fibrotic and granulomatous disorders: a bronchoalveolar lavage study.Toll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary disease.Whole cigarette smoke increased the expression of TLRs, HBDs, and proinflammory cytokines by human gingival epithelial cells through different signaling pathways.In vivo function of airway epithelial TLR2 in host defense against bacterial infectionExpression of Toll-like receptor 9 in nose, peripheral blood and bone marrow during symptomatic allergic rhinitis.Cigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8(+) T cells in chronic obstructive pulmonary disease.The role of TLR2 and bacterial lipoprotein in enhancing airway inflammation and immunityVirus-like particle-induced protection against MRSA pneumonia is dependent on IL-13 and enhancement of phagocyte function.IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation.Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke.Cigarette smoke inhibits macrophage sensing of Gram-negative bacteria and lipopolysaccharide: relative roles of nicotine and oxidant stress.Cigarette smoke represses the innate immune response to asbestos.COPD disease severity and innate immune response to pathogen-associated molecular patternsSmoking decreases the response of human lung macrophages to double-stranded RNA by reducing TLR3 expression.Toll-like receptors, transduction-effector pathways, and disease diversity: evidence of an immunobiological paradigm explaining all human illness?Toll-like receptors: their roles in bacterial recognition and respiratory infections.Characterization of TLR-induced inflammatory responses in COPD and control lung tissue explants.Bioinformatic analysis of microRNA and mRNA Regulation in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease.Signal transduction pathways linking the activation of alveolar macrophages with the recruitment of neutrophils to lungs in chronic obstructive pulmonary disease.MiR-344b-1-3p targets TLR2 and negatively regulates TLR2 signaling pathway.Immunity status of invasive pulmonary aspergillosis patients with structural lung diseases in Chinese adults.Innate immune recognition in infectious and noninfectious diseases of the lung.The role of toll-like receptors in acute and chronic lung inflammation.Impact of smoking on inflammation: overview of molecular mechanisms.Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease.Bacterial superinfection following lung inflammatory disorders.Lung cell-specific modulation of LPS-induced TLR4 receptor and adaptor localization.Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics.MD2 expression is reduced in large airways of smokers and COPD smokers.
P2860
Q22305860-E196ACA7-693D-42BE-AFCC-3B8C5E782A30Q27693862-151ED0D7-88A2-42C3-A06C-52A7F4B0B43AQ28082222-C6159D34-0901-4EAC-840C-364216413A4FQ28085163-C7D44A69-D12D-455C-A754-1829242DC351Q28396982-A781C605-292A-4487-AD1D-52B5C90D6FB9Q28731253-35EAB5FB-338F-4C38-BDCF-6BFE46649841Q28742573-558B9C13-3D60-4B14-AF00-6C09E58FE3BEQ30525313-49575FB0-D74C-4116-BA51-9540D5CC3ECDQ33590992-D080995E-5B6C-437E-9FA0-92FF01228F85Q33634527-844F35BD-35EC-42F3-8E13-10D16B58ED53Q33790352-3278A9FE-6447-4F2F-8573-9FAFBDF7F59AQ34243304-EF133D1D-C92F-4B2F-B6A5-2F82D4A34AEDQ34404971-86B32622-D63A-4FF8-8E88-73D9580D7FCBQ34540931-3C109C82-FC7B-4F85-A68A-8324AE9C260FQ34784955-FF4A0F1A-0727-439F-9A2F-578308D239C4Q35663366-3363BD04-7AD2-46A8-8419-E0A5A5B6F843Q35677380-CF91FAFB-0A2B-4FF6-8B33-2005DCF02DB4Q35927593-25D943AE-D030-4840-AC23-D36A386F9D7DQ36071784-0A082D2F-53B9-4A43-B012-DA06069B1F3AQ36110505-B7808A58-5FA3-4759-9FC0-FB97B25638C0Q36372827-6B15F14B-233B-43E9-A596-7AEAE9450AAAQ36456871-8A544941-1A69-4333-9370-D3EC0D376DD9Q36597836-946897CA-7044-4F95-A6A8-B893769D0E4EQ36672850-430B3B3C-6A99-4DDF-A603-F2AAFE2F6310Q36690891-0634359A-8DBC-45E2-91F6-E795DC3C358AQ37198685-E309CDAF-8A75-4A99-AE76-41832312F79EQ37228738-D5B35BAB-FADB-4ABF-AB18-D775B6AF4CACQ37306024-87B61502-79AC-446D-A98A-1A86E9724443Q37566648-52C9BB17-2EFB-46D8-B3E0-B65CD610EDD5Q37618178-E725770A-51B0-4675-95FF-62F6EBF7F38AQ37652831-8C09DD5D-EF18-40CA-9D62-8188CAB1879CQ37677599-315A8680-14FE-445E-A16D-B3FEB783A663Q37694915-24D50634-574D-4165-9F79-8577658940EEQ37812405-0A7482A0-B185-45C4-8FED-3BA62425E0A6Q37836485-459DBD5F-0050-4967-A3AE-FBE106233BDAQ37860435-5A40C801-6174-46F4-BF2F-2E040164A462Q38078465-150DDA03-3681-497A-BABD-8DB1F45CE449Q38241199-1DC38FF6-614B-4DE4-AD49-0A8787425DC6Q38557048-83153EC8-6F35-4CFE-B70E-EF2114715861Q38864812-89BBAE69-8ED5-4C75-818D-C20621D06269
P2860
Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Toll-like receptor 2 expressio ...... ette smokers and COPD patients
@ast
Toll-like receptor 2 expressio ...... ette smokers and COPD patients
@en
Toll-like receptor 2 expressio ...... ette smokers and COPD patients
@nl
type
label
Toll-like receptor 2 expressio ...... ette smokers and COPD patients
@ast
Toll-like receptor 2 expressio ...... ette smokers and COPD patients
@en
Toll-like receptor 2 expressio ...... ette smokers and COPD patients
@nl
prefLabel
Toll-like receptor 2 expressio ...... ette smokers and COPD patients
@ast
Toll-like receptor 2 expressio ...... ette smokers and COPD patients
@en
Toll-like receptor 2 expressio ...... ette smokers and COPD patients
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Toll-like receptor 2 expressio ...... ette smokers and COPD patients
@en
P2093
Bernhard Schaaf
Daniel Droemann
Klaus Dalhoff
Peter Zabel
Thorsten Tiedje
P2860
P2888
P3181
P356
10.1186/1465-9921-6-68
P407
P577
2005-07-08T00:00:00Z
P5875
P6179
1000872796